SPOTLIGHT -
Phase 1 Study of Apimostinel for Depression Doses First Participants
The drug is in development for the treatment of acute depressive disorders and depression with suicidality.
Phase 3 Trial of Dexmedetomidine for Bipolar I or II, Schizophrenia Doses First Participants
The phase 3 SERENITY III trial investigating at-home use of dexmedetomidine (BXCL501) sublingual film for agitation associated with bipolar I or II disorder or schizophrenia has started.
From the Pages of Psychiatric Times: November 2022
The experts weighed in on a wide variety of psychiatric issues for the November 2022 issue of Psychiatric Times.
Thinking Beyond the Guidelines: Evidence-Based Novel Therapies for Bipolar Depression
In this CME article, learn how to apply novel treatment approaches for patients with bipolar depression.
Be a Light
Acknowledging the impact of holidays on others, and what to do when things get dark.
Covering the Basics: LGBTQ+ Terminology
Do you know these terms?
Affirming Evidence-Based Care for Young Patients Who Are Transgender or Gender Diverse
Psychiatrists are in a unique position to empower their patients by recognizing and addressing key issues surrounding gender and sexuality.
The Health Care Professional Ethical Choice: Ukraine, Iran, and Whether or When to Risk and Resist
What would it take for psychiatrists and other physicians in the United States to collectively resist risks to the public’s health and mental health?
Ukraine Now: Never so Difficult, Never so Easy
An update from Ukraine.
The Importance of Avoiding Implicit Bias in Advocating for Patients
"Our own implicit biases come into play at times whether we like it or not, especially when it comes to frequently controversial medications."
To Address Climate Change, This Psychiatrist Goes Where No One Has Gone Before
Psychiatry and inner space—closer than you think.
What’s Your Favorite Holiday Activity?
Tell us about your holiday traditions for a chance to be featured in our Holiday Traditions series.
The Week in Review: November 21-25
From the unique challenges of treating physician-patients to updates on MDMA and psilocybin research and access, here are highlights from the week in Psychiatric Times.
Leveraging GAT to Address Sleep Burden in Youth
New research explores the impact of GAT on TGNC youth.
Cheerful and Tearful Over Thanksgiving Weekend
The two sides of the Thanksgiving coin… what are they and what do they mean?
Tales From the Clinic: Leading by Case Example
Have you missed the latest episodes of the series Tales From the Clinic: The Art of Psychiatry?
Broaching the Topic of Gratitude
How can you foster gratitude in your patients?
Psychiatrist Humility and Patient Empowerment
“Both doctors and patients know best.”
Concurrent Treatment With SRIs and Anticoagulants: Minimizing the Hemorrhagic Hazard
An important adverse effect of SRIs: their association with increased bleeding.
Senators Introduce New Bill to Promote Research and Access to MDMA, Psilocybin
A new bill, the Breakthrough Therapies Act, would encourage the reclassification of MDMA and psilocybin from schedule I to schedule II drugs.
Thanksgivukkah
Combining Thanksgiving, Hanukkah, and December birthday celebrations for the ultimate unique family dinner.
The Benefits and Limitations of Resilience
While resilience is beneficial to mental health, we need to reduce the reasons individuals require resilience.
"Christianity and Psychiatry" Examines Faith and Tradition vs Medical and Scientific Knowledge
"This volume is a fascinating incursion into a field that everybody talks about, but few examine in depth."
Driving Advances in Drug Discovery for Mental Health Conditions
Understanding and addressing the unmet therapeutic needs of individuals living with mental health conditions.
If You Have Children, Talk to Them
The importance of normalizing discussions about the 4 Ss with children.
“Oh No, My Patient is a Physician!” Hurdles When Treating Physician-Patients
Caring for physician-patients can be a challenge…
Advances and Challenges in Adult ADHD
What are the advances in adult ADHD?
Add 30 Exclamation Points to “Remember Transgender Individuals This Weekend”!
On Saturday night at a LGBTQ+ Club in Colorado Springs, 5 were killed and at least 25 injured.
The Week in Review: November 14-18
From the cardiac adverse effects of lithium to the road to over-the-counter naloxone, here are highlights from the week in Psychiatric Times.
AMA Announces New Policies Supporting Reproductive Health Care Rights
Policies include opposition to government involvement in medical practice and support of access to abortion care.
